Skip to content
Home/Companies/Biotech/Karius
Karius

Karius

Biotech·United States·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Karius?

Karius is an American Biotech company, currently owned by Seventure Partners since 2020.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Seventure Partners
Investor
Seventure Partners
Sport & Performance Capital · 2019 · VC

Key facts

HQUnited States
SectorBiotech
Websitekariusdx.com

More from Sport & Performance Capital

Other portfolio companies in the same fund.

Zenniz
Zenniz
Active
ConsumerFinlande· 2026
Anybuddy
Anybuddy
Active
HospitalityFrance· 2025
Ekstere
Ekstere
Active
ConsumerFrance· 2025
Exo
Exo
Active
ConsumerFrance· 2024
Baouw
Baouw
Active
ConsumerFrance· 2023
bsport
bsport
Active
ConsumerFrance· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Karius?

Karius is currently owned by Seventure Partners, through Sport & Performance Capital, since 2020.

When did Seventure Partners acquire Karius?

Seventure Partners acquired Karius in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue